CAS 89000-32-8
:[5-(4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-4-(dimethylamino)-2-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-[5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-y
Description:
The chemical substance with the name provided is a complex organic compound characterized by multiple functional groups and a polycyclic structure. It features a tetrahydropyran moiety, which is indicative of its potential for forming hydrogen bonds and participating in various chemical reactions. The presence of hydroxyl (-OH) groups suggests that the compound may exhibit solubility in polar solvents and could engage in hydrogen bonding, influencing its reactivity and biological activity. The dimethylamino groups imply basicity, which may enhance its interaction with biological targets, potentially affecting pharmacological properties. Additionally, the compound's intricate stereochemistry, denoted by specific configurations at various chiral centers, may play a crucial role in its biological activity and specificity. Overall, this substance is likely to be of interest in medicinal chemistry, particularly for its potential therapeutic applications, though its complexity may also pose challenges in synthesis and characterization.
Formula:C45H76N2O15
InChI:InChI=1/C45H76N2O15/c1-25-22-31(20-21-48)40(62-44-42(59-30(6)49)38(47(10)11)39(28(4)58-44)61-37-24-45(7,53)43(52)29(5)57-37)41(54-12)33(50)23-35(51)55-26(2)16-14-13-15-17-34(25)60-36-19-18-32(46(8)9)27(3)56-36/h13-15,17,21,25-29,31-34,36-44,50,52-53H,16,18-20,22-24H2,1-12H3/b14-13+,17-15+/t25-,26-,27?,28?,29?,31+,32?,33-,34+,36?,37?,38?,39?,40+,41+,42?,43?,44?,45?/m1/s1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
2’-O-Acetylspiramycin I
CAS:Controlled ProductFormula:C45H76N2O15Color and Shape:NeatMolecular weight:885.092'-O-Acetylspiramycin I
CAS:<p>2'-O-Acetylspiramycin I is a semi-synthetic derivative of spiramycin, which is a macrolide antibiotic originally sourced from the bacterium *Streptomyces ambofaciens*. The modification involves the acetylation at the 2'-hydroxyl group of spiramycin, enhancing certain pharmacokinetic properties.</p>Formula:C45H76N2O15Purity:Min. 95%Molecular weight:885.09 g/mol



